2A Pharma

2A Pharma is a clinical stage Swedish/Danish biopharmaceutical company focused on discovering, developing and commercialising novel, cost effective prophylactic and therapeutic vaccines based on our patented AAVLP platform.

Our Mission

To develop novel, cost effective prophylactic and therapeutic vaccines based on the AAVLP platform for the benefit of both future vaccine recipients and our investors.

LEARN MORE

Recent news

2A Pharma is a clinical stage Swedish/Danish biopharmaceutical company focused on discovering, developing and commercialising novel, cost effective prophylactic and therapeutic vaccines based on our patented AAVLP Platform.

Jeanette presents E-poster at IPVC 2021

The virtual 34th International Papillomavirus Conference took place last week, from November 15-19. The conference’s theme this year was: ‘Research and education for HPV elimination’.

...

READ MORE

Clinical trials explained

On November 4, Jeanette Prangsgaard held a presentation at the ‘Clinical Trials’ even, organised by Synapse – Life Science Connect Aalborg.

...

READ MORE

Dosing completed

All volunteers have now received three doses of 2AP01 (AAVLP-HPV), our very broad spectrum HPV vaccine formulated without adjuvant. The vaccine is well tolerated and no serious adverse events (SAEs)have been observed to date.
...

READ MORE